Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

The Meaning of Self-efficacy for Symptom Management in the Acute Phase of Hematopoietic Stem Cell Transplantation.

White LL, Cohen MZ, Berger AM, Kupzyk KA, Bierman PJ.

Cancer Nurs. 2019 Jan 23. doi: 10.1097/NCC.0000000000000685. [Epub ahead of print]

PMID:
30676398
2.

Self-Efficacy for Management of Symptoms and Symptom Distress in Adults With Cancer: An Integrative Review.

White LL, Cohen MZ, Berger AM, Kupzyk KA, Bierman PJ.

Oncol Nurs Forum. 2019 Jan 13;46(1):113-128. doi: 10.1188/19.ONF.113-128.

PMID:
30547965
3.

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.

Morschhauser F, Fowler NH, Feugier P, Bouabdallah R, Tilly H, Palomba ML, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Daguindau N, Le Gouill S, Pica GM, Martin Garcia-Sancho A, López-Guillermo A, Larouche JF, Ando K, Gomes da Silva M, André M, Zachée P, Sehn LH, Tobinai K, Cartron G, Liu D, Wang J, Xerri L, Salles GA; RELEVANCE Trial Investigators.

N Engl J Med. 2018 Sep 6;379(10):934-947. doi: 10.1056/NEJMoa1805104.

4.

NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Armand P, Bello CM, Benitez CM, Bierman PJ, Chen R, Dabaja B, Dean R, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Maddocks K, Maloney DG, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Rabinovitch R, Seropian S, Tao R, Winter JN, Yahalom J, Burns JL, Ogba N.

J Natl Compr Canc Netw. 2018 Mar;16(3):245-254. doi: 10.6004/jnccn.2018.0013.

PMID:
29523663
5.

Solid Organ Transplantation in Patients With a History of Lymphoma.

Bierman PJ.

J Oncol Pract. 2018 Jan;14(1):11-17. doi: 10.1200/JOP.2017.028480.

PMID:
29324208
6.

Perceived Self-Efficacy: A Concept Analysis for Symptom Management in Patients With Cancer
.

White LL, Cohen MZ, Berger AM, Kupzyk KA, Swore-Fletcher BA, Bierman PJ.

Clin J Oncol Nurs. 2017 Dec 1;21(6):E272-E279. doi: 10.1188/17.CJON.E272-E279.

PMID:
29149118
7.

Bariatric Implant-Associated Anaplastic Large-Cell Lymphoma.

Manikkam Umakanthan J, McBride CL, Greiner T, Yuan J, Sanmann J, Bierman PJ, Lunning MA, Bociek RG.

J Oncol Pract. 2017 Dec;13(12):838-839. doi: 10.1200/JOP.2017.026153. Epub 2017 Sep 25. No abstract available.

PMID:
28945505
8.

Rituximab Improves the Outcome of Patients With Grade 3 Follicular Lymphoma Receiving Anthracycline-Based Therapy.

Yuan J, Greiner TC, Fu K, Smith LM, Aoun P, Chan WC, Bierman PJ, Bociek RG, Vose JM, Armitage JO, Weisenburger DD.

Clin Lymphoma Myeloma Leuk. 2017 Aug;17(8):488-497.e2. doi: 10.1016/j.clml.2017.06.006. Epub 2017 Jun 16.

PMID:
28842137
9.

NCCN Guidelines Insights: Antiemesis, Version 2.2017.

Berger MJ, Ettinger DS, Aston J, Barbour S, Bergsbaken J, Bierman PJ, Brandt D, Dolan DE, Ellis G, Kim EJ, Kirkegaard S, Kloth DD, Lagman R, Lim D, Loprinzi C, Ma CX, Maurer V, Michaud LB, Nabell LM, Noonan K, Roeland E, Rugo HS, Schwartzberg LS, Scullion B, Timoney J, Todaro B, Urba SG, Shead DA, Hughes M.

J Natl Compr Canc Netw. 2017 Jul;15(7):883-893. doi: 10.6004/jnccn.2017.0117.

PMID:
28687576
10.

Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Benitez CM, Bernat K, Bierman PJ, Blum KA, Chen R, Dabaja B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Maloney DG, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Poppe M, Rabinovitch R, Seropian S, Smith M, Winter JN, Yahalom J, Burns J, Ogba N, Sundar H.

J Natl Compr Canc Netw. 2017 May;15(5):608-638.

PMID:
28476741
11.

Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia.

Khanal N, Bociek RG, Chen B, Vose JM, Armitage JO, Bierman PJ, Maness LJ, Lunning MA, Gundabolu K, Bhatt VR.

Am J Hematol. 2016 Nov;91(11):E468-E472. doi: 10.1002/ajh.24526. Epub 2016 Aug 29.

12.

Kikuchi's Disease Masquerading As Refractory Lymphoma.

Kallam A, Bierman PJ, Bociek RG.

J Oncol Pract. 2016 Jan;12(1):94-6. doi: 10.1200/JOP.2015.009910. No abstract available.

PMID:
26759472
13.

Combined systemic and ocular chemotherapy for anterior segment metastasis of systemic mantle cell lymphoma.

Agarwal A, Sadiq MA, Rhoades WR, Jack LS, Hanout M, Bierman PJ, West WW, Nguyen QD.

J Ophthalmic Inflamm Infect. 2015 Dec;5(1):30. doi: 10.1186/s12348-015-0060-1. Epub 2015 Oct 8.

14.

Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group Experience.

Bhatt VR, Loberiza FR Jr, Smith LM, Armitage JO, Greiner TC, Bast M, Lunning MA, Bierman PJ, Vose JM, Bociek RG.

Leuk Lymphoma. 2016;57(6):1327-34. doi: 10.3109/10428194.2015.1094801. Epub 2015 Oct 16.

PMID:
26377137
15.

Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.

Bhatt VR, Balasetti V, Jasem JA, Giri S, Armitage JO, Loberiza FR Jr, Bociek RG, Bierman PJ, Maness LJ, Vose JM, Fayad P, Akhtari M.

Clin Lymphoma Myeloma Leuk. 2015 Oct;15(10):606-11. doi: 10.1016/j.clml.2015.06.004. Epub 2015 Jun 19.

PMID:
26184063
16.

Differentiating malignant hypertension-induced thrombotic microangiopathy from thrombotic thrombocytopenic purpura.

Khanal N, Dahal S, Upadhyay S, Bhatt VR, Bierman PJ.

Ther Adv Hematol. 2015 Jun;6(3):97-102. doi: 10.1177/2040620715571076.

17.

Hodgkin lymphoma, version 2.2015.

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Benitez CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Khan N, Maloney DG, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Poppe M, Rabinovitch R, Seropian S, Tsien C, Winter JN, Yahalom J, Burns JL, Sundar H; National comprehensive cancer network.

J Natl Compr Canc Netw. 2015 May;13(5):554-86.

18.

Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome.

Caponetti GC, Dave BJ, Perry AM, Smith LM, Jain S, Meyer PN, Bast M, Bierman PJ, Bociek RG, Vose JM, Armitage JO, Aoun P, Fu K, Greiner TC, Chan WC, Sanger WG, Weisenburger DD.

Leuk Lymphoma. 2015;56(11):3082-9. doi: 10.3109/10428194.2015.1034699. Epub 2015 May 12.

PMID:
25827211
19.

Mortality patterns among recipients of autologous hematopoietic stem cell transplantation for lymphoma and myeloma in the past three decades.

Bhatt VR, Loberiza FR Jr, Jing H, Bociek RG, Bierman PJ, Maness LJ, Vose JM, Armitage JO, Akhtari M.

Clin Lymphoma Myeloma Leuk. 2015 Jul;15(7):409-415.e1. doi: 10.1016/j.clml.2015.02.024. Epub 2015 Mar 5.

PMID:
25816932
20.

Surgery for primary central nervous system lymphoma: is it time for reevaluation?

Bierman PJ.

Oncology (Williston Park). 2014 Jul;28(7):632-7. Review.

21.

MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab.

Perry AM, Alvarado-Bernal Y, Laurini JA, Smith LM, Slack GW, Tan KL, Sehn LH, Fu K, Aoun P, Greiner TC, Chan WC, Bierman PJ, Bociek RG, Armitage JO, Vose JM, Gascoyne RD, Weisenburger DD.

Br J Haematol. 2014 May;165(3):382-91. doi: 10.1111/bjh.12763. Epub 2014 Feb 8.

PMID:
24506200
22.

Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphoma.

William BM, Allen MS, Loberiza FR Jr, Bociek RG, Bierman PJ, Armitage JO, Vose JM.

Biol Blood Marrow Transplant. 2014 Apr;20(4):536-42. doi: 10.1016/j.bbmt.2014.01.004. Epub 2014 Jan 14.

23.

Insights on practice variations in the management of lymphoma and leukemia.

Loberiza FR Jr, Cannon AC, Cannon AJ, Bierman PJ.

Leuk Lymphoma. 2014 Nov;55(11):2449-56. doi: 10.3109/10428194.2014.881480. Epub 2014 Mar 7. Review.

PMID:
24410589
24.

Cardiac magnetic resonance imaging for the assessment of the myocardium after doxorubicin-based chemotherapy.

Lunning MA, Kutty S, Rome ET, Li L, Padiyath A, Loberiza F, Bociek RG, Bierman PJ, Vose JM, Armitage JO, Porter TR.

Am J Clin Oncol. 2015 Aug;38(4):377-81. doi: 10.1097/COC.0b013e31829e19be.

PMID:
24192805
25.

Central nervous system cancers.

Nabors LB, Ammirati M, Bierman PJ, Brem H, Butowski N, Chamberlain MC, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hesser D, Holdhoff M, Junck L, Lawson R, Loeffler JS, Maor MH, Moots PL, Morrison T, Mrugala MM, Newton HB, Portnow J, Raizer JJ, Recht L, Shrieve DC, Sills AK Jr, Tran D, Tran N, Vrionis FD, Wen PY, McMillian N, Ho M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2013 Sep 1;11(9):1114-51.

26.

Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation for Hodgkin lymphoma.

William BM, Loberiza FR Jr, Whalen V, Bierman PJ, Bociek RG, Vose JM, Armitage JO.

Clin Lymphoma Myeloma Leuk. 2013 Aug;13(4):417-23. doi: 10.1016/j.clml.2013.03.009. Epub 2013 Jun 15.

PMID:
23773453
27.

Phase II trial of 131-Iodine tositumomab with high-dose chemotherapy and autologous stem cell transplantation for relapsed diffuse large B cell lymphoma.

Vose JM, Bierman PJ, Loberiza FR, Enke C, Hankins J, Bociek RG, Chan WC, Weisenburger DD, Armitage JO.

Biol Blood Marrow Transplant. 2013 Jan;19(1):123-8. doi: 10.1016/j.bbmt.2012.08.013. Epub 2012 Aug 29.

28.

Recognizing unusual manifestations of Hodgkin lymphoma.

Barber NA, Bierman PJ.

Curr Hematol Malig Rep. 2012 Sep;7(3):186-92. doi: 10.1007/s11899-012-0131-4. Review.

PMID:
22777500
29.

Current and emerging pharmacotherapies for primary CNS lymphoma.

Prodduturi P, Bierman PJ.

Clin Med Insights Oncol. 2012;6:219-31. doi: 10.4137/CMO.S7752. Epub 2012 May 21.

30.

Lymph node-induced immune tolerance in chronic lymphocytic leukaemia: a role for caveolin-1.

Gilling CE, Mittal AK, Chaturvedi NK, Iqbal J, Aoun P, Bierman PJ, Bociek RG, Weisenburger DD, Joshi SS.

Br J Haematol. 2012 Jul;158(2):216-231. doi: 10.1111/j.1365-2141.2012.09148.x. Epub 2012 May 10.

PMID:
22571278
31.

Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines.

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Maloney DG, Mansur D, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Poppe M, Pro B, Winter JN, Yahalom J, Sundar H; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2012 May;10(5):589-97.

PMID:
22570290
32.

Novel therapy for therapy-resistant mantle cell lymphoma: multipronged approach with targeting of hedgehog signaling.

Hegde GV, Nordgren TM, Munger CM, Mittal AK, Bierman PJ, Weisenburger DD, Vose JM, Sharp JG, Joshi SS.

Int J Cancer. 2012 Dec 15;131(12):2951-60. doi: 10.1002/ijc.27602. Epub 2012 May 21.

33.

Antiemesis.

Ettinger DS, Armstrong DK, Barbour S, Berger MJ, Bierman PJ, Bradbury B, Ellis G, Kirkegaard S, Kloth DD, Kris MG, Lim D, Michaud LB, Nabati L, Noonan K, Rugo HS, Siler D, Sorscher SM, Stelts S, Stucky-Marshall L, Todaro B, Urba SG; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2012 Apr;10(4):456-85. No abstract available.

PMID:
22491046
34.

The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma.

Mitrovic Z, Bast M, Bierman PJ, Bociek RG, Vose JM, Chan WC, Armitage JO.

Br J Haematol. 2012 May;157(3):401-3. doi: 10.1111/j.1365-2141.2011.08998.x. Epub 2012 Jan 9. No abstract available.

PMID:
22224728
35.

Sarcoidosis mimicking recurrent lymphoma.

Li W, Holdeman K, Laurini JA, Bierman PJ, Vose JM, Bociek RG, Armitage JO.

Am J Hematol. 2012 Jul;87(7):711-2. doi: 10.1002/ajh.22270. Epub 2011 Dec 27. No abstract available.

36.

Transplantation for lymphoma: good for the brain as well as the body?

Bierman PJ, Armitage JO.

Biol Blood Marrow Transplant. 2012 Jan;18(1):1-2. doi: 10.1016/j.bbmt.2011.11.006. Epub 2011 Nov 9. No abstract available.

37.

Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantation.

Gu K, Weisenburger DD, Fu K, Chan WC, Greiner TC, Aoun P, Smith LM, Bast M, Liu Z, Bociek RG, Bierman PJ, Armitage JO, Vose JM.

Hematol Oncol. 2012 Sep;30(3):143-9. doi: 10.1002/hon.1017. Epub 2011 Oct 18.

38.

Small lymphocytic lymphoma in a patient with CREST syndrome.

William BM, Harbert T, Ganti AK, Bierman PJ.

Hematol Oncol Stem Cell Ther. 2011;4(3):132-5.

39.

Hodgkin lymphoma.

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Bello CM, Bierman PJ, Blum KA, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Maloney DG, Mansur D, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Poppe M, Pro B, Weiss L, Winter JN, Yahalom J; NCCN Hodgkin Lymphoma.

J Natl Compr Canc Netw. 2011 Sep 1;9(9):1020-58. No abstract available.

PMID:
21917626
40.

Central nervous system cancers.

Brem SS, Bierman PJ, Brem H, Butowski N, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hesser D, Junck L, Linette GP, Loeffler JS, Maor MH, Michael M, Moots PL, Morrison T, Mrugala M, Nabors LB, Newton HB, Portnow J, Raizer JJ, Recht L, Shrieve DC, Sills AK Jr, Vrionis FD, Wen PY; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2011 Apr;9(4):352-400. No abstract available.

PMID:
21464144
41.

Radiation for diffuse large B-cell lymphoma: more questions than answers.

Bierman PJ, Enke CA.

Oncology (Williston Park). 2010 Nov 30;24(13):1213-4. No abstract available.

42.

Late relapse in patients with diffuse large B-cell lymphoma.

Vose JM, Weisenburger DD, Loberiza FR, Arevalo A, Bast M, Armitage J, Bierman PJ, Bociek RG, Armitage JO.

Br J Haematol. 2010 Nov;151(4):354-8. doi: 10.1111/j.1365-2141.2010.08330.x. Epub 2010 Sep 29.

PMID:
20880118
43.

I-131 tositumomab.

William BM, Bierman PJ.

Expert Opin Biol Ther. 2010 Aug;10(8):1271-8. doi: 10.1517/14712598.2010.504707. Review.

PMID:
20590521
44.

Role of hematopoietic stem cell transplantation in the treatment of non-Hodgkin's lymphoma.

Bierman PJ, Phillips GL.

Cancer Treat Res. 2009;144:357-97. doi: 10.1007/978-0-387-78580-6_15. Review. No abstract available.

PMID:
19779882
45.

Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study.

Loberiza FR Jr, Cannon AJ, Weisenburger DD, Vose JM, Moehr MJ, Bast MA, Bierman PJ, Bociek RG, Armitage JO.

J Clin Oncol. 2009 Nov 10;27(32):5376-82. doi: 10.1200/JCO.2009.22.0038. Epub 2009 Sep 14.

46.

Looking back (and ahead) at salvage treatment for non-Hodgkin lymphoma.

Bierman PJ, Armitage JO.

Oncology (Williston Park). 2009 Jun;23(7):619, 625. No abstract available.

47.

Antiemesis. Clinical Practice Guidelines in Oncology.

Ettinger DS, Armstrong DK, Barbour S, Berger MJ, Bierman PJ, Bradbury B, Ellis G, Kirkegaard S, Kloth DD, Kris MG, Lim D, Markiewicz MA, Nabati L, Nesheiwat C, Rugo HS, Sorscher SM, Stucky-Marshal L, Todaro B, Urba S.

J Natl Compr Canc Netw. 2009 May;7(5):572-95. No abstract available.

PMID:
19460282
48.

Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes.

van Besien K, Carreras J, Bierman PJ, Logan BR, Molina A, King R, Nelson G, Fay JW, Champlin RE, Lazarus HM, Vose JM, Hari PN.

Biol Blood Marrow Transplant. 2009 May;15(5):554-63. doi: 10.1016/j.bbmt.2009.01.012. Epub 2009 Mar 9.

49.

Adult Burkitt lymphoma: advances in diagnosis and treatment.

Aldoss IT, Weisenburger DD, Fu K, Chan WC, Vose JM, Bierman PJ, Bociek RG, Armitage JO.

Oncology (Williston Park). 2008 Nov 30;22(13):1508-17. Review.

50.

The role of bendamustine in the treatment of indolent non-Hodgkin lymphoma.

Aldoss IT, Blumel SM, Bierman PJ.

Cancer Manag Res. 2009 Nov 12;1:155-65.

Supplemental Content

Loading ...
Support Center